SINGULAR GENOMICS SYSTEMS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4042 USD | +0.90% |
|
+2.33% | -12.15% |
| 03-20 | UBS Adjusts Singular Genomics Systems Price Target to $0.50 From $0.40, Maintains Neutral Rating | MT |
| 03-18 | Transcript : Singular Genomics Systems, Inc., Q4 2023 Earnings Call, Mar 18, 2024 |
Chart calendar Singular Genomics Systems, Inc.
1cfaf81058686f53f55c5b60878cb209.PwrhnGQ6GlZQZFy-VCp3uKhzA0AMemuRiUzLtYEaSC8.Ej25yS1oKRoWCgTbZ0IS-e9LTXE8FQnc-Tuv8eVUJxZIPpLvKGNfDhZVKw~f7d33bc53db55ab10d0e0e1834d9a8a7
Upcoming events on Singular Genomics Systems, Inc.
Past events on Singular Genomics Systems, Inc.
| 18/03/2024 20:30 | Q4 2023 Earnings Call |
| 18/03/2024 20:05 | Q4 2023 Earnings Release |
| 14/11/2023 21:30 | Q3 2023 Earnings Call |
| 14/11/2023 21:01 | Q3 2023 Earnings Release |
| 21/09/2023 16:30 | Gilmartin Group Emerging Growth Company Showcase |
| 16/08/2023 17:00 | UBS MedTech Tools and Genomics Summit |
| 09/08/2023 21:30 | Q2 2023 Earnings Call |
| 09/08/2023 21:01 | Q2 2023 Earnings Release |
| 13/06/2023 19:20 | Goldman Sachs Global Healthcare Conference |
| 25/05/2023 21:00 | Annual General Meeting |
| 09/05/2023 21:30 | Q1 2023 Earnings Call |
| 09/05/2023 21:01 | Q1 2023 Earnings Release |
| 07/03/2023 16:10 | Cowen Health Care Conference |
| 02/03/2023 21:30 | Q4 2022 Earnings Call |
| 02/03/2023 21:01 | Q4 2022 Earnings Release |
| 05/02/2023 | Advances in Genome Biology and Technology General Meeting |
| 12/01/2023 18:30 | JP Morgan Healthcare Conference |
| 07/11/2022 21:30 | Q3 2022 Earnings Call |
| 07/11/2022 21:01 | Q3 2022 Earnings Release |
| 31/08/2022 21:30 | Inaugural Gilmartin Group Emerging Growth Company Showcase |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,77 0,73 4.28% | 2,91 2,87 1.29% | 2,42 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -60,1 -61,0 1.37% | -91,1 -97,4 6.54% | -99,3 -93,4 -6.27% | -98,6 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -61,3 -61,6 0.55% | -93,5 -98,9 5.46% | -103 -98,4 -4.42% | -91,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -90,9 -95,0 4.34% | -94,8 -93,0 -1.96% | -85,0 |
|
Net income Million USD | Released Forecast Spread | -27,9 | -98,8 -98,1 -0.67% | -90,9 -98,6 7.79% | -94,8 -93,5 -1.43% | -87,7 |
|
EPS USD | Released Forecast Spread | -2,64 | -2,10 -1,82 -15.16% | -1,28 -1,42 9.91% | -1,30 -1,34 3.01% | -1,17 |
| Announcement Date | 22/03/21 | 02/03/22 | 02/03/23 | 18/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,05 - | 0,00 0,00 - | 0,77 0,73 4.28% | 0,86 1,24 -30.42% | 0,51 1,15 -56.05% | 0,46 1,28 -63.79% | 1,08 1,04 3.54% | 0,69 | 0,44 | 0,68 | 0,96 |
|
EBITDA Million USD | Released Forecast Spread | -19,3 -21,6 10.7% | -21,6 -22,4 3.62% | -23,6 -26,0 9.23% | -24,1 -27,1 11.19% | -21,8 -27,9 21.97% | -24,6 -24,4 -0.62% | -26,7 -25,9 -3.1% | -23,7 -26,7 11.36% | -24,3 -22,8 -6.4% | -23,9 | -25,7 | ||
|
EBIT Million USD | Released Forecast Spread | -19,7 -21,1 6.87% | -22,0 -23,0 4.38% | -24,2 -27,4 11.38% | -24,7 -28,8 14.33% | -22,5 -29,8 24.4% | -25,4 -25,7 1.24% | -27,6 -26,5 -4% | -24,5 -27,8 11.62% | -25,3 -23,7 -6.82% | -25,9 | -22,1 | -20,8 | -21,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -24,0 -28,0 14.35% | -21,1 -26,0 18.84% | -23,6 -23,0 -2.75% | -25,6 -26,0 1.62% | -22,4 -27,0 17.19% | -23,2 -22,0 -5.68% | -19,0 | -19,0 | |||||
|
Net income Million USD | Released Forecast Spread | -22,0 -24,6 10.43% | -24,0 -26,4 9.31% | -23,8 -26,0 8.64% | -21,1 -26,1 19.08% | -23,6 -23,2 -1.75% | -25,6 -25,9 1.18% | -22,4 -27,0 17.19% | -23,2 -22,0 -5.68% | -19,0 | -19,0 | |||
|
EPS USD | Released Forecast Spread | -0,27 -0,30 9.18% | -0,31 -0,34 7.46% | -0,34 -0,41 16.79% | -0,33 -0,43 22.4% | -0,29 -0,44 33.65% | -0,33 -0,36 9.42% | -0,35 -0,37 5.12% | -0,31 -0,39 21.26% | -0,31 -0,34 9.96% | -0,35 | -0,30 | -0,27 | -0,27 |
| Announcement Date | 02/03/22 | 10/05/22 | 09/08/22 | 07/11/22 | 02/03/23 | 09/05/23 | 09/08/23 | 14/11/23 | 18/03/24 | - | - | - | - |
More events
Past sector events for Singular Genomics Systems, Inc.
| 26/04/2024 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 06:00 | BB BIOTECH AG: Q1 2024 Earnings Release |
| 25/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 25/04/2024 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 25/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 12:00 | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 25/04/2024 07:00 | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- OMIC Stock
- Calendar Singular Genomics Systems, Inc.
